Press Release FeedGet the RSS feed
Menu

Business Wire

Materialise Reports Second Quarter and Half-Year 2026 Results

Business Wire

Regulated information1

LEUVEN, Belgium, August 27, 2026--Materialise NV (Euronext & NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced its financial results for the second quarter and the six months ended June 30, 2026.

Highlights – Second Quarter 2026

  • Total revenue increased by 8.1% to 70,073 kEUR for the second quarter of 2026 compared to 64,831 kEUR for the corresponding 2025 period.

  • Adjusted EBITDA increased by 15.7% to 9,593 kEUR for the second quarter of 2026 compared to 8,288 kEUR for the second quarter of 2025.

  • Adjusted EBIT increased by 26.9% to 3,880 kEUR for the second quarter of 2026 from 3,058 kEUR for the second quarter of 2025.

  • Net profit for the second quarter of 2026 amounted to 3,331 kEUR, or 0.06 EUR per diluted share, compared to net profit of 199 kEUR, or 0.00 EUR per diluted share, for the corresponding 2025 period.

  • The net cash position at quarter end was 74,214 kEUR, 1,388 kEUR higher compared to the net cash position as of March 31, 2026 while 2,903 kEUR was invested in share buybacks, underscoring continued strong operational cash generation.

Highlights – Half-Year 2026

  • Driven by a strong 9.6% growth in our Materialise Medical segment, total revenue increased by 3.9% to 136,349 kEUR for the first half of 2026 compared to 131,210 kEUR for the first half of 2025.

  • Gross profit as a percentage of revenue for the first half of 2026 was 57.0%, compared to 56.8% for the first half of 2025.

  • Adjusted EBITDA increased by 22.2% to 17,642 kEUR for the first half of 2026 compared to 14,434 kEUR for the first half of 2025. Adjusted EBIT increased by 71.4% to 6,351 kEUR for the first half of 2026 from 3,703 kEUR for the first half of 2025.

  • Net profit for the first half of 2026 amounted to 5,152 kEUR, or 0.09 EUR per diluted share, compared to a net loss of (337) kEUR, or (0.01) EUR per diluted share, for the first half of 2025.

  • Total cash reserves amounted to 133,735 kEUR at the end of the first half of 2026. The net cash position increased by 3,409 kEUR during the first half of 2026, while 5,212 kEUR was invested in share buybacks.

CEO Brigitte de Vet-Veithen commented, "In the second quarter of 2026, Materialise delivered strong financial results with consolidated revenue exceeding EUR 70 million, up 8% year over year. Double-digit revenue growth in our Materialise Medical segment was complemented by renewed growth in our Manufacturing segment driven by strong performance in our aerospace & defense focus markets. Combined with disciplined cost management and focused execution, this revenue growth translated into a significant improvement in operational and bottomline profitability. Our net cash position further strengthened supported by consistent operating cash flow while we continued the execution of our share buyback program.

  1. CybersecurityZumigo, Inc.Zumigo InstaAuth Achieves FIDO2 Server Certification, Bringing Frictionless, Secure Passkey Sign-In to Banks, Fintechs, and MerchantsFull certification from the FIDO Alliance validates InstaAuth's phishing-resistant passkey authentication across real-world devices, available now in the Auth Widget and IDV Builder SAN JOSE, Calif., October 19, 2026--Zumigo, Inc., a leader in mobile identity intelligence and fraud prevention, today an
  2. FinanceXencor, Inc.Xencor to Host Webcast to Discuss Results From the Phase 1 Study of XmAb819 in Advanced Clear Cell Renal Cell CarcinomaPASADENA, Calif., October 19, 2026--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, will host a webcast on Monday, October 26 at 7:00 a.m. EDT (4:00 a.m. PDT) to discuss results from the Phase 1
  3. FinanceNRG Energy, Inc.NRG Energy, Inc. Announces Quarterly DividendCompanies: NRG EnergyHOUSTON, October 19, 2026--NRG Energy, Inc. (NYSE: NRG) today announced that its Board of Directors declared a quarterly dividend on the Company's common stock of $0.475 per share, or $1.90 per share on an annualized basis. The dividend is payable on November 16, 2026, to stockholders of record as of N
  4. HealthcareFrontier Medicines to Present First Clinical Data for FMC-376, an Equipotent KRAS G12C ON+OFF Inhibitor, at ESMO Congress 2026BOSTON & SOUTH SAN FRANCISCO, Calif., October 19, 2026--Frontier Medicines Corporation, a clinical-stage precision medicines company unlocking the proteome to develop small molecule oncology and immunology drugs against previously undruggable disease-causing targets, today announced the company will pr
  5. FinanceTaiho Oncology, Inc. and Cullinan Therapeutics, Inc.Zipalertinib Demonstrates Clinically Meaningful Intracranial Antitumor Activity in Patients with NSCLC with EGFR Exon 20 Insertion or Uncommon EGFR Mutations and Active CNS MetastasesIntracranial Objective Response Rate of 30.2% was observed in 43 evaluable patients Results to be shared in poster presentation at ESMO Congress 2026 PRINCETON, N.J. & CAMBRIDGE, Mass., October 19, 2026--Taiho Oncology, Inc. and Cullinan Therapeutics, Inc. (Nasdaq: CGEM) today announced results from Co
  6. FinanceBlackSky Technology Inc.BlackSky to Host Third Quarter 2026 Results Conference CallHERNDON, Va., October 19, 2026--BlackSky Technology Inc. (NYSE: BKSY ) will host a live webcast and conference call to discuss third quarter 2026 financial results and its business outlook on Thursday, November 5, 2026, at 8:30 a.m. EST. A press release with BlackSky's financial results will be release